BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2154920)

  • 21. [Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer].
    Zubrikhina GN; Ermilova VD; Kuz'mina ZV; Bassalyk LS
    Arkh Patol; 1989; 51(3):10-6. PubMed ID: 2545183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonpalpable breast masses: radiologic predictability of malignancy.
    Hermann G; Keller RJ; Schwartz IS; Papatestas A; Rajagopalan B; Rabinowitz JG
    Can Assoc Radiol J; 1990 Jun; 41(3):130-2. PubMed ID: 2162236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microfluorometric grading of mammary tumors. A pilot study.
    Patek E; Johannisson E; Krauer F; Riotton G
    Anal Quant Cytol; 1980 Dec; 2(4):264-71. PubMed ID: 6258463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographically occult breast cancer. A pathologic and radiologic study.
    Holland R; Hendriks JH; Mravunac M
    Cancer; 1983 Nov; 52(10):1810-9. PubMed ID: 6313174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
    Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
    J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.
    Ewers SB; Långström E; Baldetorp B; Killander D
    Cytometry; 1984 Jul; 5(4):408-19. PubMed ID: 6468179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of sonography in patients with breast cancer presenting as an axillary mass.
    Park SY; Kim EK; Oh KK; Lee KS; Park BW
    Korean J Radiol; 2002; 3(3):189-93. PubMed ID: 12271164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonpalpable breast lesions: evaluation by means of fine-needle aspiration cytology.
    Hann L; Ducatman BS; Wang HH; Fein V; McIntire JM
    Radiology; 1989 May; 171(2):373-6. PubMed ID: 2539608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.
    Yildirim-Assaf S; Coumbos A; Hopfenmüller W; Foss HD; Stein H; Kühn W
    J Clin Pathol; 2007 Jun; 60(6):649-55. PubMed ID: 17557867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The reliability of microspectrophotometric and flow cytometric nuclear DNA measurements in adenocarcinomas of the breast.
    Fallenius AG; Askensten UG; Skoog LK; Auer GU
    Cytometry; 1987 May; 8(3):260-6. PubMed ID: 3595349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance and staging of nonpalpable carcinomas of the breast.
    Schwartz GF; Feig SA; Patchefsky AS
    Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammographic guidewire localization of nonpalpable breast lesions.
    Jeter DD; Vest GR; Buday SJ
    Am Surg; 1991 Jul; 57(7):431-3. PubMed ID: 1647713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA analysis of ductal carcinoma in situ of the breast. A comparison with histologic features.
    Killeen JL; Namiki H
    Cancer; 1991 Dec; 68(12):2602-7. PubMed ID: 1657363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-palpable invasive breast carcinomas from the Stockholm screening project.
    von Rosen A; Frisell J; Glas U; Hellström L; Nilsson R; Skoog L; Auer G
    Acta Oncol; 1989; 28(1):23-7. PubMed ID: 2706131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult malignant breast lesions in 114 patients: relationship to age and the presence of microcalcifications.
    Hermann G; Janus C; Schwartz IS; Papatestas A; Hermann DG; Rabinowitz JG
    Radiology; 1988 Nov; 169(2):321-4. PubMed ID: 2845470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically occult breast lesions: localization and significance.
    Rosenberg AL; Schwartz GF; Feig SA; Patchefsky AS
    Radiology; 1987 Jan; 162(1 Pt 1):167-70. PubMed ID: 3024209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochemical identification of quiescent and growth-activated tumor cells.
    Auer G; Ono J; Caspersson TO
    Anal Quant Cytol; 1983 Mar; 5(1):5-8. PubMed ID: 6303170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma.
    Kaplan C; Matallana R; Wallack MK
    Am Surg; 1990 Jan; 56(1):40-2. PubMed ID: 2153010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced detection of preinvasive breast cancer: combined role of mammography and needle localization biopsy.
    Molloy M; Azarow K; Garcia VF; Daniel JR
    J Surg Oncol; 1989 Mar; 40(3):152-4. PubMed ID: 2537442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.